XML 65 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Consolidated Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net losses $ (31,496) $ (6,888) $ (87,596)
Less: Net earnings/(losses) from discontinued operations, net of tax (5,318) 4,538 (67,705)
Losses from continuing operations (26,178) (11,426) (19,891)
Adjustments to reconcile net earnings/(losses) to net cash provided by operating activities:      
Depreciation and amortization 48,740 43,753 43,633
Amortization of finance costs 7,196 5,375 6,893
Write-off of inventory 1,140 0 0
Impairment of goodwill 0 2,055 11,907
Impairment of other intangible assets, other assets and property, plant and equipment 36,430 3,837 8,153
Undistributed earnings of unconsolidated companies (8,133) (7,895) (6,627)
Tax on earnings of unconsolidated companies 1,691 5,771 2,270
Share-based compensation 10,388 6,761 6,752
Excess share-based compensation tax benefit (267) 0 0
Change in deferred income tax (2,078) 4,204 (11,328)
Gain on extinguishment of debt (3,517) 0 0
Gain on disposal of property, plant and equipment and capital lease 0 (1,514) (13,372)
Change in provisions for uncertain tax positions (2,526) 160 (3,004)
Proceeds from insurance settlements 7,841 2,524 2,428
Effect of exchange rates on net losses (3,839) (1,104) (6,213)
Change in assets and liabilities, net of effects from acquisitions:      
Accounts receivable 414 8,546 3,667
Due from unconsolidated companies (2,414) (3,232) (3,519)
Prepaid expense and other (1,000) 4,498 3,307
Inventories (1,742) 611 (2,600)
Escrow, prepaid customer deposits and security for package travel 3,839 (1,221) (664)
Accounts payable (1,320) (4,891) 3,548
Accrued liabilities (3,628) (9,345) 13,000
Deferred revenue 3,629 4,401 1,286
Other, net 551 (6,803) 6,399
Net cash provided by operating activities from continuing operations 65,217 45,065 46,025
Net cash provided by/(used in) operating activities from discontinued operations 1,907 144 (3,451)
Net cash provided by operating activities 67,124 45,209 42,574
Cash flows from investing activities:      
Capital expenditures (66,646) (97,048) (59,909)
Acquisitions, net of cash acquired 0 (3,296) (1,605)
Investments in unconsolidated companies (5,532) (4,858) (1,541)
Increase in restricted cash (4,705) (7,523) (5,805)
Release of restricted cash 8,580 1,013 1,558
Deposits received for sale of assets 4,000 0 0
Government grants received 1,043 0 0
Proceeds from sale of property, plant and equipment 291 0 42,036
Net cash used in investing activities from continuing operations (62,969) (111,712) (25,266)
Net cash provided by investing activities from discontinued operations 18,812 88,655 12,058
Net cash used in investing activities (44,157) (23,057) (13,208)
Cash flows from financing activities:      
Proceeds from working capital facilities 133 0 0
Payments on working capital facilities 0 0 (1,072)
Issuance costs of common shares 0 0 (157)
Exercised stock options and vested share awards 7 3 3
Excess share-based compensation tax benefit 267 0 0
Issuance of long-term debt 135,388 105,008 125,209
Debt issuance costs (4,305) (2,613) (4,036)
Principal payments under long-term debt (124,444) (121,372) (209,794)
Net cash provided by/(used in) financing activities from continuing operations 7,046 (18,974) (89,847)
Net cash provided by financing activities from discontinued operations 0 0 0
Net cash provided by/(used in) financing activities 7,046 (18,974) (89,847)
Effect of exchange rate changes on cash and cash equivalents 302 (303) 898
Net increase/(decrease) in cash and cash equivalents 30,315 2,875 (59,583)
Cash and cash equivalents at beginning of year 92,844 89,969 149,552
Cash and cash equivalents at end of year $ 123,159 $ 92,844 $ 89,969